	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Amgen	USD 5.14B	775M	2025-12
Arrowhead Research	USD 64.2M	223.53M	2025-09
Astellas Pharma	JPY 183.68B	31.98B	2025-12
AstraZeneca	USD 5.23B	272M	2025-09
Bayer	EUR 1.51B	1.28B	2025-09
Biogen	USD 573.2M	253.7M	2025-12
BioMarin Pharmaceutical	USD -5.26M	300.71M	2025-09
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Daiichi Sankyo	JPY 101.6B	22.81B	2025-03
Eli Lilly	USD 7.88B	378.1M	2025-09
Exelixis	USD 248.93M	28.02M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Incyte	USD 414.5M	92.42M	2025-12
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Moderna	USD -790M	582M	2025-12
Nektar Therapeutics	USD -31.81M	70K	2023-09
Novartis	USD 5.88B	290M	2025-09
Novartis	USD 5.84B	235M	2025-09
Pfizer	USD 6.08B	351M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09

Agios Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.